{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:59:56Z","timestamp":1793296796976,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bioorg.2023.106432","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T02:02:26Z","timestamp":1676858546000},"page":"106432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Design, synthesis, and evaluation of hydrazones as dual inhibitors of ryanodine receptors and acetylcholinesterases for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"133","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-3188","authenticated-orcid":false,"given":"Yunlei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1311-1220","authenticated-orcid":false,"given":"Yajing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106432_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115891","article-title":"Design, synthesis, and biological activity of novel semicarbazones as potent Ryanodine receptor1 inhibitors of Alzheimer\u2019s disease","volume":"29","author":"Dai","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106432_b0010","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer's disease facts and figures, Alzheimer's & Dementia 17(3) (2021) 327-406.","DOI":"10.1002\/alz.12328"},{"key":"10.1016\/j.bioorg.2023.106432_b0015","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1037\/tra0000793","article-title":"Impact of COVID-19 pandemic restrictions on community-dwelling caregivers and persons with dementia","volume":"12","author":"Greenberg","year":"2020","journal-title":"Psychol. Trauma Theory Res. Pract. Policy"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106432_b0020","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jagp.2020.09.008","article-title":"Family Communication in Long-Term Care During a Pandemic: Lessons for Enhancing Emotional Experiences","volume":"28","author":"Monin","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bioorg.2023.106432_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174847","article-title":"Promising heterocycle-based scaffolds in recent (2019\u20132021) anti-Alzheimer's drug design and discovery","volume":"920","author":"Dorababu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106432_b0030","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acs.jmedchem.0c01863","article-title":"Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate","volume":"64","author":"Zhou","year":"2021","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106432_b0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/cn100069c","article-title":"Selective Acetylcholinesterase Inhibitor Activated by Acetylcholinesterase Releases an Active Chelator with Neurorescuing and Anti-Amyloid Activities","volume":"1","author":"Zheng","year":"2010","journal-title":"ACS Chem. Nerosci."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106432_b0040","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","article-title":"The importance of neuritic plaques and tangles to the development and evolution of AD","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106432_b0045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106432_b0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn1886","article-title":"Ageing and neuronal vulnerability","volume":"7","author":"Mattson","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106432_b0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J. Neurosci."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106432_b0060","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers","volume":"280","author":"Demuro","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"7179","key":"10.1016\/j.bioorg.2023.106432_b0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature06616","article-title":"Rapid appearance and local toxicity of amyloid-\u03b2 plaques in a mouse model of Alzheimer\u2019s disease","volume":"451","author":"Meyer-Luehmann","year":"2008","journal-title":"Nature"},{"issue":"6560","key":"10.1016\/j.bioorg.2023.106432_b0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/379074a0","article-title":"Activation of K+ channels and suppression of neuronal activity by secreted \u03b2-amyloid-precursor protein","volume":"379","author":"Furukawa","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.106432_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105670","article-title":"Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer's disease","volume":"121","author":"Kaur","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106432_b0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"Ekavali, A review on Alzheimer's disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106432_b0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1517\/14728222.11.2.161","article-title":"Targeting acetylcholinesterase to treat neurodegeneration","volume":"11","author":"Holzgrabe","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106432_b0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.med.57.121304.131442","article-title":"Current Pharmacotherapy for Alzheimer's Disease","volume":"57","author":"Lle\u00f3","year":"2006","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106432_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41582-020-00454-9","article-title":"Aducanumab and the FDA - where are we now?","volume":"17","author":"Fillit","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"6604","key":"10.1016\/j.bioorg.2023.106432_b0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.add9993","article-title":"Blots on a field?","volume":"377","author":"Piller","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2023.106432_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1989.tb12485.x","article-title":"Calcium, membranes, aging, and Alzheimer's disease","volume":"568","author":"Khachaturian","year":"1989","journal-title":"Introduction and overview, Annals of the New York Academy of Sciences"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106432_b0110","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00335-001-2044-8","article-title":"A genomic sequence analysis of the mouse and human microtubule-associated protein tau","volume":"12","author":"Poorkaj","year":"2001","journal-title":"Mamm. Genome"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106432_b0115","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1471-4159.2007.04603.x","article-title":"Inhibition of protein phosphatases induces transport deficits and axonopathy","volume":"102","author":"Yang","year":"2007","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106432_b0120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signalling in alzheimer's disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106432_b0125","doi-asserted-by":"crossref","first-page":"15295","DOI":"10.1038\/ncomms15295","article-title":"Tau association with synaptic vesicles causes presynaptic dysfunction","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106432_b0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1073858407299730","article-title":"The pathogenesis of Alzheimers disease is it a lifelong \u201ccalciumopathy\u201d?","volume":"13","author":"Stutzmann","year":"2007","journal-title":"Neuroscientist"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106432_b0135","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/neup.12354","article-title":"Microglia and brain macrophages: An update","volume":"37","author":"Sasaki","year":"2017","journal-title":"Neuropathology"},{"key":"10.1016\/j.bioorg.2023.106432_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mam.2015.05.005","article-title":"Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?","volume":"43\u201344","author":"Rosenberg","year":"2015","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106432_b0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1474-9726.2007.00295.x","article-title":"Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store","volume":"6","author":"Thibault","year":"2007","journal-title":"Aging Cell"},{"issue":"4\u20135","key":"10.1016\/j.bioorg.2023.106432_b0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuint.2007.10.002","article-title":"Calcium dysregulation in Alzheimer's disease","volume":"52","author":"Bojarski","year":"2008","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106432_b0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/nbdi.1998.0176","article-title":"Calcium Responses in Fibroblasts from Asymptomatic Members of Alzheimer's Disease Families","volume":"5","author":"Etcheberrigaray","year":"1998","journal-title":"Neurobiol. Dis."},{"issue":"11 Pt B","key":"10.1016\/j.bioorg.2023.106432_b0160","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","article-title":"Calcium signaling in Alzheimer's disease & therapies","volume":"1865","author":"Tong","year":"2018","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Cell Res."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106432_b0165","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1242\/dmm.006841","article-title":"A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug","volume":"4","author":"Copenhaver","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bioorg.2023.106432_b0170","doi-asserted-by":"crossref","unstructured":"S.K. Danoff, C.D. Ferris, C. Donath, G.A. Fischer, S. Munemitsu, A. Ullrich, S.H. Snyder, C.A. Ross, Inositol 1,4,5-trisphosphate receptors: distinct neuronal and nonneuronal forms derived by alternative splicing differ in phosphorylation, Proc. Nat. Acad. Sci. USA 88(7) (1991) 2951-5.","DOI":"10.1073\/pnas.88.7.2951"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106432_b0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ceca.2009.08.005","article-title":"Endoplasmic reticulum Ca2+ release through ryanodine and IP3 receptors contributes to neuronal excitotoxicity","volume":"46","author":"Ruiz","year":"2009","journal-title":"Cell Calcium"},{"issue":"363","key":"10.1016\/j.bioorg.2023.106432_b0180","doi-asserted-by":"crossref","first-page":"re15","DOI":"10.1126\/stke.3632006re15","article-title":"The inositol 1,4,5-trisphosphate receptor (IP3R) and its regulators: sometimes good and sometimes bad teamwork","volume":"2006","author":"Choe","year":"2006","journal-title":"Sci. STKE"},{"issue":"6868","key":"10.1016\/j.bioorg.2023.106432_b0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106432_b0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jmb.2014.08.004","article-title":"Ryanodine receptors: allosteric ion channel giants","volume":"427","author":"Van Petegem","year":"2015","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106432_b0195","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00013.2002","article-title":"Ryanodine receptor calcium release channels","volume":"82","author":"Fill","year":"2002","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106432_b0200","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1567205017666200522204722","article-title":"Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease","volume":"17","author":"Abou","year":"2020","journal-title":"Curr. Alzheimer Res."},{"issue":"7407","key":"10.1016\/j.bioorg.2023.106432_b0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106432_b0210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/epirev\/mxf001","article-title":"Pharmacologic Agents Associated with a Preventive Effect on Alzheimer\u2019s Disease: A Review of the Epidemiologic Evidence","volume":"24","author":"in \u2018t Veld","year":"2002","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.bioorg.2023.106432_b0215","article-title":"Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?","volume":"2","author":"Imbimbo","year":"2010","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106432_b0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0773.1989.tb00621.x","article-title":"Whole-Body Autoradiography of 14C-Dantrolene in the Marmoset Monkey","volume":"64","author":"Wuis","year":"1989","journal-title":"Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106432_b0225","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/cn100007x","article-title":"Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Nerosci."},{"issue":"18","key":"10.1016\/j.bioorg.2023.106432_b0230","doi-asserted-by":"crossref","first-page":"10091","DOI":"10.1021\/acs.jmedchem.9b01596","article-title":"Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data","volume":"63","author":"Tinworth","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106432_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113827","article-title":"A tacrine-tetrahydroquinoline heterodimer potently inhibits acetylcholinesterase activity and enhances neurotransmission in mice","volume":"226","author":"Ip","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"6407","key":"10.1016\/j.bioorg.2023.106432_b0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106432_b0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41593-018-0076-6","article-title":"Memory formation depends on both synapse-specific modifications of synaptic strength and cell-specific increases in excitability","volume":"21","author":"Lisman","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"21","key":"10.1016\/j.bioorg.2023.106432_b0250","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1523\/JNEUROSCI.22-21-09626.2002","article-title":"Induction and experience-dependent consolidation of stable long-term potentiation lasting months in the hippocampus","volume":"22","author":"Abraham","year":"2002","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106432_b0255","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1073858403259119","article-title":"Properties and mechanisms of LTP maintenance","volume":"9","author":"Abraham","year":"2003","journal-title":"Neuroscientist"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106432_b0260","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hipo.23213","article-title":"The history of long-term potentiation as a memory mechanism: Controversies, confirmation, and some lessons to remember","volume":"30","author":"Dringenberg","year":"2020","journal-title":"Hippocampus"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106432_b0265","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1002\/jnr.24936","article-title":"Limiting RyR2 open time prevents Alzheimer's disease-related deficits in the 3xTG-AD mouse model","volume":"99","author":"Liu","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bioorg.2023.106432_b0270","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12543","article-title":"Increased RyR2 open probability induces neuronal hyperactivity and memory loss with or without Alzheimer's disease-causing gene mutations","author":"Yao","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106432_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108169","article-title":"Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not \u03b2-Amyloid Accumulation","volume":"32","author":"Yao","year":"2020","journal-title":"Cell Rep."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:45:34Z","timestamp":1758617134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":55,"alternative-id":["S0045206823000925"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106432","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of hydrazones as dual inhibitors of ryanodine receptors and acetylcholinesterases for Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106432"}}